Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges (Q37904507)

25 August 2017

1 reference

title

Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges (English)

1 reference

25 August 2017

Circulating Tumor Cells in Breast Cancer: Detection Systems, Molecular Characterization, and Future Challenges (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

7 December 2024

1 reference

Evi S. Lianidou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21784769

7 December 2024

Athina Markou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21784769

7 December 2024

language of work or name

English

0 references

publication date

22 July 2011

1 reference

full work available at URL

25 August 2017

http://pdfs.semanticscholar.org/8598/14c71f0c8235d811e809f0a99611bc612983.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21784769

http://academic.oup.com/clinchem/article-pdf/57/9/1242/32656688/clinchem1242.pdf

7 December 2024

file format

Portable Document Format

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

7 December 2024

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

1242-1255

1 reference

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Medicine. Cancer's circulation problem

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

7 December 2024

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Is there a role for circulating tumor cells in the management of breast cancer?

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumor cells as markers for cancer risk assessment and treatment monitoring

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

A pooled analysis of bone marrow micrometastasis in breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

What's new on circulating tumor cells? A meeting report

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Statistical considerations for enumeration of circulating tumor cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Isolation of rare circulating tumour cells in cancer patients by microchip technology

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Novel Immunofluorescence Protocol for Multimarker Assessment of Putative Disseminating Breast Cancer Stem Cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Comparison of two methods for enumerating circulating tumor cells in carcinoma patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular biomarker analyses using circulating tumor cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular mechanisms of metastasis in breast cancer--clinical applications

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

HER-2 gene amplification can be acquired as breast cancer progresses

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

HER2-positive circulating tumor cells in breast cancer

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Therapeutic implications of the cancer stem cell hypothesis.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumor cells in patients with breast cancer dormancy

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Epithelial-to-mesenchymal transitions and circulating tumor cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

Parallel progression of primary tumours and metastases

7 December 2024

1 reference

https://api.crossref.org/works/10.1373/CLINCHEM.2011.165068

7 December 2024

Identifiers

DOI

1 reference

25 August 2017

1 reference